Exactly. This is obviously the problem, so the main thing that the clinicians are excited about, to have rare diseases that are normally not diagnosed, not being diagnosed based on genomic information, is kind of adverse to the privacy application. And it seems like that has been going down as a societal consensus. So, it’s worth basically doing it for the benefit.